Hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will be given bread containing yeast extract, in which part of the regular salt has been replaced with yeast extract. The loaves are complete
the type of bread will be hidden from both researchers and participants. People must visit the study site weekly and receive their bread. Each person is given 14 loaves of bread (considering the consu
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Adults 18 to 75 years old People who have high blood pressure and have had their blood pressure diagnosed by a doctor are eligible to enter the study.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women People with chronic diseases, including liver, kidney, lung, thyroid, and cancer Those who follow a special diet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic and diastolic blood pressure. Timepoint: At the beginning and end of the study and every two weeks during the study. Method of measurement: sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Uric acid. Timepoint: Before and after the intervention. Method of measurement: uric acid photometric.;Fasting glucose. Timepoint: Before and after the intervention. Method of measurement: FBS photometric.;Creatinine. Timepoint: Before and after the intervention. Method of measurement: Creatinine photometric.;Urea. Timepoint: Before and after the intervention. Method of measurement: BUN photometric.;Serum lipid profile. Timepoint: Before and after the intervention. Method of measurement: lipid profile photometric.;Sodium in 24-hour urine. Timepoint: Before and after the intervention. Method of measurement: Na atomic absorption.;Potassium in 24-hour urine. Timepoint: Before and after the intervention. Method of measurement: K atomic absorption.;Creatinine in 24-hour urine. Timepoint: Before and after the intervention. Method of measurement: Creatinine atomic absorption. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarima chaichi khorsand
Shiraz University of Medical Sciences
Outcome results
None listed